Syndopa CR 50 + 200 mg Tablet

Syndopa CR 50 + 200 mg Tablet is a controlled-release anti-Parkinsonian medicine that contains carbidopa 50 mg and levodopa 200 mg in each tablet. It is used to help relieve the movement symptoms of Parkinson’s disease, such as stiffness, slowness, tremor, and trouble with balance. As a carbidopa + levodopa tablet, it works by replacing dopamine activity in the brain. This specific strength is designed for patients who need a stronger levodopa amount and a longer-lasting effect than lower-dose tablets.

How it works: Levodopa crosses into the brain and is converted to dopamine, which helps improve Parkinson’s movement symptoms. Carbidopa blocks levodopa breakdown before it reaches the brain, so more levodopa gets where it is needed and nausea may be reduced.

The Syndopa CR 50 + 200 mg Tablet is a higher-strength controlled-release option, so it is usually chosen after a doctor has already assessed how well lower strengths control symptoms. Because it releases medicine more slowly, it is meant to help provide steadier symptom control and may be better suited for people who need longer coverage rather than a rapid onset. It is not the same as an immediate-release tablet and should be used only as directed for your prescribed schedule.

• Parkinson’s disease symptom control
• Stiffness and muscle rigidity
• Slow movement (bradykinesia)
• Tremor
• Motor fluctuations in selected patients

• Swallow the Syndopa CR 50 + 200 mg Tablet whole with water; do not crush, split, or chew it unless your doctor specifically tells you to.
• Take it at the same times each day to keep symptom control more even.
• You may take it with or without food, but a high-protein meal can make levodopa work less well for some people.
• If it upsets your stomach, taking it with a small snack may help, but avoid changing the schedule on your own.
• Rise slowly from sitting or lying down, since this medicine can cause dizziness or low blood pressure.
• Follow your prescribed timing carefully; controlled-release tablets should not be used as a quick rescue dose for sudden symptoms.

Each Syndopa CR 50 + 200 mg Tablet provides carbidopa 50 mg plus levodopa 200 mg in a controlled-release tablet. The dose may be taken once daily or divided into multiple doses depending on your symptoms, response, and tolerability; your doctor decides the exact schedule. The maximum daily amount is individualized and should not be increased without medical supervision, especially with this higher-strength tablet.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Carbidopa + Levodopa may include:

• Nausea
• Dizziness or lightheadedness
• Sleepiness or sudden drowsiness
• Headache
• Dry mouth
• Constipation
• Vivid dreams or sleep changes

• This is a higher-strength controlled-release tablet, so it should be used only under a doctor’s guidance after symptoms have been assessed.
• Use caution if you have heart disease, low blood pressure, liver disease, kidney disease, glaucoma, asthma, or a history of mental health problems.
• Alcohol can worsen dizziness, sleepiness, and poor coordination with Syndopa CR 50 + 200 mg Tablet.
• This medicine can impair driving or operating machinery, especially when starting treatment or after a dose increase.
• Do not stop taking it suddenly unless your prescriber tells you to, because symptoms can worsen and withdrawal-like problems can occur.
• Tell your doctor if you have had melanoma or unexplained skin changes, because Parkinson’s medicines require skin monitoring.
• If you develop sudden sleep attacks, confusion, or abnormal movements, contact your prescriber promptly.

• MAO inhibitors or recent MAOI use
• Antipsychotic medicines and some anti-nausea drugs that block dopamine
• Iron supplements or multivitamins containing iron
• High-protein meals that may reduce levodopa absorption/effect
• Blood pressure medicines that can add to dizziness

Store Syndopa CR 50 + 200 mg Tablet in its original strip/box at room temperature, away from moisture, heat, and direct light.